Medifast MED reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Medifast beat estimated earnings by 13.54%, reporting an EPS of $1.09 versus an estimate of $0.96.
Revenue was down $146.23 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.06 which was followed by a 2.5% drop in the share price the next day.
Here's a look at Medifast's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | 1.06 | 1.44 | 2.40 | 2.22 |
EPS Actual | 2.12 | 2.77 | 3.67 | 3.70 |
Revenue Estimate | 232.10M | 253.47M | 319.52M | 330.10M |
Revenue Actual | 235.87M | 296.19M | 348.98M | 337.25M |
To track all earnings releases for Medifast visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.